Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Increased awareness, earlier detection bring relief to challenges of Prader-Willi syndrome
-
- Concerns related to radiation exposure emerge in Japan
- Conflicts of interest may prompt physicians to pen articles promoting menopausal HT
- ‘Diabetes belt’ identified in southern US
- Diabetes uncontrolled in seven countries
- DURABLE trial: Twice-daily insulin lispro mix improved glycemic control
- Estrogen plus GH increases height for girls with Turner’s syndrome
- Evidence review places benefits, drawbacks of testosterone therapy in context for physicians
- Extended dosing interval approved for lanreotide injection
-
- Kentucky becomes first state to require licenses for diabetes educators
- Medically underserved girls evaluated for short stature less often
- Mediterranean diet cuts risk for metabolic syndrome
- NIH announces new plan to combat diabetes
- Nitroglycerin may improve postmenopausal bone strength
- Safety recommendations for I-131 vary among health care providers
- Study of otelixizumab in type 1 diabetes did not meet primary endpoint
- Study to evaluate why diabetes complications are not present in all patients
-
- Vitamin D controversies examined
- Diabetes and accountable care: A patient-centered focus Ashley Collinsworth, MPH; William L. Roberts, MHA, CPA; Neil Fleming, PhD; Donna Rice, RN, CDE
- Perithyroidal masses in a young woman Stephanie L. Lee, MD, PhD, ECNU
- Consider screening ‘at risk’ newborns for neonatal hypoglycemia
- Early menopausal symptoms not associated with increased risk for CVD events
- Exposure to endocrine disruptors associated with early onset of menopause
- Fatty liver increases risk for type 2 diabetes
- Fertility, ovarian function may be affected by high-dose estrogen used to stunt growth
-
- Metabolic syndrome found in more than half of patients after liver transplantation
- Metformin showed best results for first-line treatment of type 2 diabetes
- Researchers identify, describe structure of HDL
- Simvastatin may boost benefits of metformin in women with PCOS
- Soy phytoestrogens increased risk for overt hypothyroidism
- Study: Pioglitazone halts progression to type 2 diabetes
- Testosterone treatment in frail, elderly men lost effect after 6 months
- Unsafe glucose monitoring practices led to HBV outbreak in assisted-living facility
-
- New formulation of bromocriptine for diabetes James R. Taylor, PharmD, CDE